semaglutide fda drug shortage list The says it's standing by its earlier decision that the of tirzepatide — the active ingredient in Eli Lilly's diabetes and weight loss drugs Mounjaro and Zepbound — is over Key things to know about

The main drawbacks of incretin-based therapies are tolerability and weight loss quality

Improved Health Metrics: Often leads to improvement in obesity-related health conditions

Clinical trials have shown that you can lose approximately 2% of your body weight in one month

Personal or family history of medullary or thyroid carcinoma Multiple endocrine neoplasia syndrome type 2 Pancreatitis Gallbladder problems Hypoglycemia (low blood sugar levels) Kidney problems Change in vision (persons with type 2 diabetes) Increase in heart rate Depression or thoughts of suicide Are there any foods I need to avoid with Ozempic/Wegovy

There is no specific antidote